Bio-Techne's Lunaphore And SIB Swiss Institute Of Bioinformatics, Have Been Awarded Innosuisse Funding To Develop AI-Based Assay Development Tools For Spatial Biology On Lunaphore's COMET To Accelerate Adoption Of Multiplex Sequential Immunofluorescence
Portfolio Pulse from Benzinga Newsdesk
Bio-Techne's subsidiary Lunaphore and the SIB Swiss Institute of Bioinformatics have received Innosuisse funding to develop AI-based assay development tools for spatial biology on Lunaphore's COMET platform. This initiative aims to accelerate the adoption of multiplex sequential immunofluorescence, a technique used in spatial biology.
December 14, 2023 | 12:22 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Bio-Techne's Lunaphore has partnered with SIB Swiss Institute of Bioinformatics to develop AI-based tools for spatial biology, funded by Innosuisse, which may enhance the capabilities of the COMET platform and drive its adoption.
The Innosuisse funding for the development of AI-based assay tools is likely to have a positive impact on Bio-Techne's stock (TECH) in the short term. The collaboration with a reputable institute like SIB and the focus on enhancing the COMET platform's capabilities could lead to increased adoption and sales, which investors may view favorably. The relevance is high as it directly involves a Bio-Techne subsidiary, and the importance is significant due to the potential for increased revenue and market share in the spatial biology field.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80